Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in Vivo.
Burch, J.D., Barrett, K., Chen, Y., DeVoss, J., Eigenbrot, C., Goldsmith, R., Ismaili, M.H., Lau, K., Lin, Z., Ortwine, D.F., Zarrin, A.A., McEwan, P.A., Barker, J.J., Ellebrandt, C., Kordt, D., Stein, D.B., Wang, X., Chen, Y., Hu, B., Xu, X., Yuen, P.W., Zhang, Y., Pei, Z.(2015) J Med Chem 58: 3806-3816
- PubMed: 25844760 
- DOI: 10.1021/jm501998m
- Primary Citation of Related Structures:  
4RFM - PubMed Abstract: 
The medicinal chemistry community has directed considerable efforts toward the discovery of selective inhibitors of interleukin-2 inducible T-cell kinase (ITK), given its role in T-cell signaling downstream of the T-cell receptor (TCR) and the implications of this target for inflammatory disorders such as asthma ...